[CLDX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 7.71%
YoY- 10.93%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 2,763 4,068 3,456 3,924 3,829 1,534 1,874 29.63%
PBT -16,407 -118,897 -22,923 -31,563 -28,566 -34,261 -32,307 -36.42%
Tax -15,798 -765 -19,082 -5,200 1,276 5,098 -5,090 113.21%
NP -16,407 -118,132 -3,841 -26,363 -28,566 -34,261 -32,307 -36.42%
Tax Rate - - - - - - - -
Total Cost 19,170 122,200 7,297 30,287 32,395 35,795 34,181 -32.06%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -593.81 -2,903.93 -111.14 -671.84 -746.04 -2,233.44 -1,723.96 -50.95%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -1.67 -12.61 -0.42 -3.05 -3.42 -4.19 -4.49 -48.37%
EPS Diluted -1.67 -12.61 -0.41 -3.05 -3.42 -4.19 -4.49 -48.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.